Abstract
A series of enediyne prodrugs with (E)- or (Z)-3-hydroxy-4-(arylmethylidene)cyclodeca-1,5- diyne scaffolds have been synthesized via an intramolecular Nozaki-Hiyama-Kishi reaction as the key step. Cytotoxicity in micro molar range against P388 cancer cell line was observed for selected compounds and a structure-activity relationship is discussed.
Keywords: enediyne, prodrug, nozaki-hiyama-kishi reaction, allylic, rearrangement, anticancer
Letters in Drug Design & Discovery
Title: Synthesis and Cytotoxicity of Enediyne Prodrugs with 3-Hydroxy-4- (arylmethylidene)cyclodeca-1,5-diyne Scaffolds
Volume: 1 Issue: 1
Author(s): Wei-Min Dai, Yukihiro Tachi, Sei-ichi Nishimoto, Xiaofen Zhong and Zhihong Guo
Affiliation:
Keywords: enediyne, prodrug, nozaki-hiyama-kishi reaction, allylic, rearrangement, anticancer
Abstract: A series of enediyne prodrugs with (E)- or (Z)-3-hydroxy-4-(arylmethylidene)cyclodeca-1,5- diyne scaffolds have been synthesized via an intramolecular Nozaki-Hiyama-Kishi reaction as the key step. Cytotoxicity in micro molar range against P388 cancer cell line was observed for selected compounds and a structure-activity relationship is discussed.
Export Options
About this article
Cite this article as:
Dai Wei-Min, Tachi Yukihiro, Nishimoto Sei-ichi, Zhong Xiaofen and Guo Zhihong, Synthesis and Cytotoxicity of Enediyne Prodrugs with 3-Hydroxy-4- (arylmethylidene)cyclodeca-1,5-diyne Scaffolds, Letters in Drug Design & Discovery 2004; 1 (1) . https://dx.doi.org/10.2174/1570180043485699
DOI https://dx.doi.org/10.2174/1570180043485699 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Induced Depressive Disorder Following the First Dose of COVID-19
Vaccine
CNS & Neurological Disorders - Drug Targets Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents A Mini-review of Computational Approaches to Predict Functions and Findings of Novel Micro Peptides
Current Bioinformatics Update on Parenteral Nutrition-Associated Liver Disease: Pathogenesis and Management
Current Nutrition & Food Science WITHDRAWAL NOTICE: Review of the Times When One-Third of the Mankind is Under Lockdown Due to Coronavirus
Coronaviruses Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?
Current Medicinal Chemistry Therapeutic Peptides: New Arsenal Against Drug Resistant Pathogens
Current Pharmaceutical Design Metal-Organic Compounds as Anticancer Agents: Versatile Building Blocks for Selective Action on G-quadruplexes
Current Medicinal Chemistry An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever
Combinatorial Chemistry & High Throughput Screening Subject Index to Volume 1
Medicinal Chemistry Reviews - Online (Discontinued) New Uses of Melatonin as a Drug; A Review
Current Medicinal Chemistry Synthesis, Biological Evaluation, Molecular Docking Study and Acute Oral Toxicity Study of Coupled Imidazole-Pyrimidine Derivatives
Letters in Drug Design & Discovery Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
Current Pharmaceutical Design The Role of Hesperidin in Cell Signal Transduction Pathway for the Prevention or Treatment of Cancer
Current Medicinal Chemistry Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets Building and Implementing a Quality Assurance/Quality Improvement Program for Clinical Research
Applied Drug Research, Clinical Trials and Regulatory Affairs Human Rhinovirus 3C Protease as a Potential Target for the Development of Antiviral Agents
Current Protein & Peptide Science Quality of Experience: A New Paradigm for Resource Management in Wireless Multimedia Networks
Recent Patents on Computer Science Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry
Current Medicinal Chemistry Current Progresses of Novel Natural Products and Their Derivatives/ Analogs as Anti-Alzheimer Candidates: an Update
Mini-Reviews in Medicinal Chemistry